Job Title

At Peter Mac we aim to continuously improve cancer care, research and education across all cancers and for all people affected by cancer: changing lives, breaking new ground. Everything we do is underpinned by our core values, Excellence, Compassion and Innovation. Welcoming people from a wide variety of different backgrounds and experiences is critical to fostering innovation, cultivating compassion, attracting and retaining top talent and providing the best possible cancer care for our patients. YOUR ROLE IN OUR FUTURE Research Nurse Level 2, or Study Coordinator Full Time, Ongoing (80 hours per fortnight with an accrued day off once per month) Parkville location with flexible, hybrid working $111,930 (Research Nurse) $90,235.60 - $103,724.40 (Study Coordinator) salary range salary packaging super 5 weeks annual leave The Parkville Cancer Clinical Trials Unit (PCCTU) co-ordinates clinical trials across the 3 institutions of the Parkville Medical precinct: The Peter MacCallum Cancer Centre, the Royal Melbourne Hospital and the Royal Womens'' Hospital. We are the largest oncology trials unit in Australia with an exciting and expanding trials portfolio. Our focus on early phase trials means that we are seeking a research nurse or study coordinator, with medical oncology/haematology experience in clinical trials to join our team. The successful candidate will have clinical trial experience in a hospital and excellent communication skills. They will also be a team player with great time management skills. For an experienced candidate, a senior research nurse or senior study coordinator position will be considered. For the full selection criteria, please see the job profile. The position is full time, ongoing. About the Role Working within a team, the Clinical Trials Research Nurse (level 2) or study coordinator will coordinate the delivery of direct and indirect care and associated data collection for concurrent research studies undertaken in the department, in accordance with the Therapeutic Goods Administration (TGA) Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) and the National Health and Medical Research Council (NHMRC) National Statement on Ethical Conduct in Research Involving Humans. Applications close: 11:59pm Monday 01 December 2025.